The renal WNK kinase pathway: A new link to hypertension

Nephrology Dialysis Transplantation

Volumn 24, Issue 4, 2009, Pages 1074-1077

  Hoorn, Ewout J ^a   Van Der Lubbe, Nils ^a   Zietse, Robert ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Aldosterone; Epithelial sodium hannel; Exosomes; Pseudohypoaldosteronism; Sodium chloride cotransporter

Indexed keywords

ALDOSTERONE; KIDNEY ENZYME; PROTEIN KINASE WNK1; PROTEIN SERINE THREONINE KINASE;

BLOOD PRESSURE; CELL MEMBRANE PERMEABILITY; CELL PROLIFERATION; CELL VOLUME; EMBRYO DEVELOPMENT; ENZYME ACTIVITY; ENZYME ANALYSIS; GENE DELETION; GENE OVEREXPRESSION; GORDON SYNDROME; INTRON; ION TRANSPORT; MISSENSE MUTATION; NEUROTRANSMISSION; NOTE; POLYMERASE CHAIN REACTION; POTASSIUM TRANSPORT; PRIORITY JOURNAL; PSEUDOHYPOALDOSTERONISM; SIGNAL TRANSDUCTION; SODIUM TRANSPORT;

ANIMALS; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; HUMANS; HYPERTENSION; MICE; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION;

EID: 65349116796     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp013     Document Type: Note

References (32)

1. Xu B, English JM, Wilsbacher JL et al. WNK1, a novel mammalian serine/threonine protein kinase lacking the catalytic lysine in subdomain II. J Biol Chem 2000; 275: 16795
2. McCormick JA,YangCL, Ellison DH.WNKkinases and renal sodium transport in health and disease: an integrated view. Hypertension 2008; 51: 588
3. Yang CL, Zhu X, Ellison DH. The thiazide-sensitive Na-Cl cotransporter is regulated by aWNK kinase signaling complex. J Clin Invest2007; 117: 3403
4. Chiga M, Rai T, Yang SS et al. Dietary salt regulates the phosphorylation of OSR1/SPAK kinases and the sodium chloride cotransporter through aldosterone. Kidney Int 2008; 74: 1403
5. Vallon V. Regulation of the Na+-Cl-cotransporter by dietary NaCl: a role for WNKs, SPAK, OSR1, and aldosterone. Kidney Int 2008; 74: 1373
6. Huang CL, Yang SS, Lin SH. Mechanism of regulation of renal ion transport by WNK kinases. Curr Opin Nephrol Hypertens 2008; 17: 519
7. O'Reilly M, Marshall E, Macgillivray T et al. Dietary electrolytedriven responses in the renal WNK kinase pathway in vivo. J Am Soc Nephrol 2006; 17: 2402
8. Wade JB, Fang L, Liu J et al. WNK1 kinase isoform switch regulates renal potassium excretion. Proc Natl Acad Sci U S A 2006; 103: 8558
9. Lazrak A, Liu Z, Huang CL. Antagonistic regulation of ROMK by long and kidney-specific WNK1 isoforms. Proc Natl Acad Sci USA2006; 103: 1615
10. Kamel KS, Oh MS, Halperin ML. Bartter's, Gitelman's, and Gordon's syndromes. From physiology to molecular biology and back, yet still some unanswered questions. Nephron 2002; 92(Suppl 1): 18
11. Wilson FH, Disse-Nicodeme S, ChoateKAet al.Human hypertension caused by mutations in WNK kinases. Science 2001; 293: 1107
12. Lalioti MD, Zhang J, Volkman HM et al. Wnk4 controls blood pressure and potassium homeostasis via regulation of mass and activity of the distal convoluted tubule. Nat Genet 2006; 38: 1124
13. Yang SS, Morimoto T, Rai T et al. Molecular pathogenesis of pseudohypoaldosteronism type II: generation and analysis of a Wnk4(D561A/+) knock-in mouse model. Cell Metab 2007; 5: 331
14. Huang CL, Kuo E. Mechanisms of disease: WNK-ing at the mechanism of salt-sensitive hypertension. Nat Clin Pract Nephrol 2007; 3: 623
15. Halperin ML, Cheema-Dhadli S, Lin SH et al. Control of potassium excretion: a Paleolithic perspective. Curr Opin Nephrol Hypertens2006; 15: 430
16. Song J, Hu X, Riazi S et al. Regulation of blood pressure, the epithelial sodium channel (ENaC), and other key renal sodium transporters by chronic insulin infusion in rats. Am J Physiol Renal Physiol 2006; 290: F1055
17. Tobin MD, Raleigh SM, Newhouse S et al. Association of WNK1 gene polymorphisms and haplotypes with ambulatory blood pressure in the general population. Circulation 2005; 112: 3423
18. Tobin MD, Timpson NJ, Wain LV et al. Common variation in the WNK1 gene and blood pressure in childhood: the Avon Longitudinal Study of Parents and Children. Hypertension 2008; 52: 974
19. Wang Y, O'Connell JR,McArdle PF et al.Whole-genome association study identifies STK39 as a hypertension susceptibility gene. Proc Natl Acad Sci USA 2008
20. Luft FC. Geneticism of essential hypertension. Hypertension 2004; 43: 1155
21. Harrap SB, Tzourio C, Cambien F et al. The ACE gene I/D polymorphism is not associated with the blood pressure and cardiovascular benefits of ACE inhibition. Hypertension 2003; 42: 297
22. Sethi AA, Nordestgaard BG, Gronholdt ML et al. Angiotensinogen single nucleotide polymorphisms, elevated blood pressure, and risk of cardiovascular disease. Hypertension 2003; 41: 1202
23. Manunta P, Lavery G, Lanzani C et al. Physiological interaction between alpha-adducin and WNK1-NEDD4L pathways on sodiumrelated blood pressure regulation. Hypertension 2008; 52: 366
24. Mayan H, Attar-Herzberg D, Shaharabany M et al. Increased urinary Na-Cl cotransporter protein in familial hyperkalaemia and hypertension. Nephrol Dial Transplant 2008; 23: 492
25. Olivieri O, Castagna A, Guarini P et al. Urinary prostasin: a candidate marker of epithelial sodium channel activation in humans. Hypertension2005; 46: 683
26. Pisitkun T, Shen RF, Knepper MA. Identification and proteomic profiling of exosomes in human urine. Proc Natl Acad Sci USA 2004; 101: 13368
27. Zhou H, Cheruvanky A, Hu X et al. Urinary exosomal transcription factors, a new class of biomarkers for renal disease. Kidney Int 2008; 74: 613
28. Zhou H, Pisitkun T, Aponte A et al. Exosomal Fetuin-A identified by proteomics: a novel urinary biomarker for detecting acute kidney injury. Kidney Int 2006; 70: 1847
29. Hoorn EJ, Pisitkun T, Zietse R et al. Prospects for urinary proteomics: exosomes as a source of urinary biomarkers. Nephrology (Carlton)2005; 10: 283
30. Cope G, Golbang A, O'Shaughnessy KM. WNK kinases and the control of blood pressure. Pharmacol Ther 2005; 106: 221
31. Noble ME, Endicott JA, Johnson LN. Protein kinase inhibitors: insights into drug design from structure. Science 2004; 303: 1800
32. Zambrowicz BP, Abuin A, Ramirez-Solis R et al. Wnk1 kinase deficiency lowers blood pressure in mice: a gene-trap screen to identify potential targets for therapeutic intervention. Proc Natl Acad Sci USA2003; 100: 14109